Bright Path Labs is a pharmaceutical company based in North Carolina. Its filings show it spends on federal lobbying related to defense, health issues, pharmacy, manufacturing, and Medicare/Medicaid. It hired Buchanan Ingersoll & Rooney to develop and execute a government relations strategy on these topics. The disclosures cover four filings totaling about $80,000 through January 20, 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr MICHAEL P STRAZZELLA
The latest disclosures for this client.
BUCHANAN INGERSOLL & ROONEY PC
3TYBUCHANAN INGERSOLL & ROONEY PC
Q2YBUCHANAN INGERSOLL & ROONEY PC
The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
BUCHANAN INGERSOLL & ROONEY PC
SOPHIA ESTUPINAN
BUCHANAN INGERSOLL & ROONEY PC
AMANDA LINCOLN
BUCHANAN INGERSOLL & ROONEY PC
BUCHANAN INGERSOLL & ROONEY PC
Q4BUCHANAN INGERSOLL & ROONEY PC
Q3BUCHANAN INGERSOLL & ROONEY PC
Q2BUCHANAN INGERSOLL & ROONEY PC
RR